IsoRay Inc


Company Update (NYSEMKT:ISR): IsoRay, Inc. Reports First Quarter Fiscal 2016 Financial Results

IsoRay, Inc. (NYSEMKT:ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for the treatment of prostate, brain, lung, …

Maxim Offers Commentary on IsoRay, Inc Following Quarterly Update

Maxim’s healthcare analyst Jason Kolbert came out today with his views on IsoRay, Inc (NYSEMKT:ISR), after the company released its financial results for the quarter ended June …

Stock Update (NYSE MKT:ISR): IsoRay, Inc. Announces Appointment of PCG Advisory Group as Investor, Public and Digital Communications Agency of Record

IsoRay, Inc. (NYSEMKT:ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, today announced it has appointed PCG Advisory Group …

Company Update (NYSE MKT:ISR): IsoRay, Inc.’s Cesium-131 Cancer Fighting Portfolio Was on Display at the American Association Of Physicists in Medicine (Aapm) Convention

IsoRay, Inc. (NYSEMKT:ISR) , a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, announced it participated at the American Association …

Company Update (NYSE MKT:ISR): IsoRay, Inc.’s Cesium-131 Selected By Chicago Prostate Cancer Center For Use In The Launch Of Study Of Prostate Cancer Treatment

IsoRay, Inc. (NYSE MKT:ISR), a medical technology company and innovator in brachytherapy and medical isotope applications, announced that Dr.

Company Update (NYSE MKT:ISR): IsoRay, Inc. Announces Appointment of New Director

IsoRay, Inc. (NYSE MKT:ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, announced the appointment, on June 18, …

Company Update (NYSE MKT:ISR): IsoRay, Inc.’s QM System Granted Continued Certification to Highest ISO Standard for Medical Device Manufacturers

IsoRay, Inc. (NYSE MKT:ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, announced the successful evaluation of its …

Company Update (NYSE MKT:ISR): Isoray, Inc.’s Intra-Cranial Brachytherapy Brain Cancer Treatments Utilizing Cesium-131 were Presented at the Brain Tumor Biotech Summit 2015

IsoRay, Inc. (NYSE MKT:ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications; announced it presented last Friday at …

IsoRay, Inc. (ISR) Stock Looks Like It’s About To Climb, Again

IsoRay, Inc. (NYSE MKT:ISR) has had a very interesting time in the market this week.

IsoRay, Inc. (ISR) Share Price Takes Roller-Coaster Ride; Maxim Analyst Remains Positive

IsoRay, Inc. (NYSEMKT:ISR) shares soared as much as 94 percent yesterday, after the company released data in an online publication regarding the first major peer reviewed …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts